Protein expression profile of human renal mesangial cells under high glucose.

Am J Nephrol

Central Laboratory, The First Hospital, China Medical University, Shenyang, China.

Published: December 2011

Background: To understand the spectrum of proteins affected by diabetic nephropathy and to characterize the molecular functions and biological processes they control, the protein expression profile of human renal mesangial cells (HMCs) under high glucose was analyzed.

Methods: HMCs were divided into a high glucose-cultured group (30 mmol/l) and a normal glucose-cultured group (5 mmol/l). The total proteins of the two groups were separated and analyzed by two-dimensional difference gel electrophoresis (DIGE). Spots that were differentially expressed were picked and digested with trypsin and subjected to MALDI-TOF MS for protein identification.

Results: 147 protein spots whose expression levels were significantly increased or decreased more than 1.5-fold in HMCs under high glucose culture were identified. 32 proteins were identified by peptide mass fingerprinting. The protein spots of phosphatidylethanolamine-binding protein 1, granulysin, ATP synthase, H(+) transporter, mitochondrial F0 complex and subunit F2 were observed only in the high glucose group. The expression of 24 proteins was upregulated by high glucose, including eosinophil cationic protein and others. The expression of 5 proteins was downregulated by high glucose, including proteasome β6 subunit precursor, among others.

Conclusion: 32 protein expressions of human glomerular mesangial cells were regulated by high glucose. In-depth analysis of these differentially expressed proteins' function and crosstalk is expected to provide an experimental basis for clarifying the pathogenesis of diabetic nephropathy.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000328733DOI Listing

Publication Analysis

Top Keywords

high glucose
28
protein expression
12
mesangial cells
12
protein
8
expression profile
8
profile human
8
human renal
8
renal mesangial
8
high
8
diabetic nephropathy
8

Similar Publications

Palmitate potentiates the SMAD3-PAI-1 pathway by reducing nuclear GDF15 levels.

Cell Mol Life Sci

January 2025

Department of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, Unitat de Farmacologia, Universitat de Barcelona, Av. Joan XXIII 27-31, 08028, Barcelona, Spain.

Nuclear growth differentiation factor 15 (GDF15) reduces the binding of the mothers' against decapentaplegic homolog (SMAD) complex to its DNA-binding elements. However, the stimuli that control this process are unknown. Here, we examined whether saturated fatty acids (FA), particularly palmitate, regulate nuclear GDF15 levels and the activation of the SMAD3 pathway in human skeletal myotubes and mouse skeletal muscle, where most insulin-stimulated glucose use occurs in the whole organism.

View Article and Find Full Text PDF

The incidence of type 2 diabetes has risen globally, in parallel with the obesity epidemic and environments promoting a sedentary lifestyle and low-quality diet. There has been scrutiny of ultra-processed foods (UPFs) as a driver of type 2 diabetes, underscored by their increasing availability and intake worldwide, across countries of all incomes. This narrative review addresses the accumulated evidence from investigations of the trends in UPF consumption and the relationship with type 2 diabetes incidence.

View Article and Find Full Text PDF

The Lentinus edodes polysaccharide (LEP) was extracted with a new subcritical water extraction (SWE) enhanced with deep eutectic solvent (DES) method and then purified with a DEAE-52 cellulose column and a Sephadex G-100 column. Two purified polysaccharides (LEP1 and LEP2) were obtained and their structure, antioxidant activity, and immunomodulatory activity were analyzed. LEP1 and LEP2 were composed of mannose, glucose, and galactose with a molar ratio of 1:12.

View Article and Find Full Text PDF

[Research advances in maturity-onset diabetes of the young].

Zhongguo Dang Dai Er Ke Za Zhi

January 2025

Department of Endocrine, Genetics and Metabolism, Children's Hospital Affiliated to Xi'an Jiaotong University, Xi'an 710003, China.

Maturity-onset diabetes of the young (MODY) is a special type of diabetes characterized by clinical features including early onset of diabetes (before 30 years of age), autosomal dominant inheritance, impaired glucose-induced insulin secretion, and hyperglycemia. So far, 14 types of MODY have been reported, accounting for about 1%-5% of the patients with diabetes. MODY often presents with an insidious onset, and although 14 subtypes have been identified for MODY, it is frequently misdiagnosed as type 1 or type 2 diabetes due to overlapping clinical features and high costs and limitations of genetic testing.

View Article and Find Full Text PDF

The development of optical sensors for label-free quantification of cell parameters has numerous uses in the biomedical arena. However, using current optical probes requires the laborious collection of sufficiently large datasets that can be used to calibrate optical probe signals to true metabolite concentrations. Further, most practitioners find it difficult to confidently adapt black box chemometric models that are difficult to troubleshoot in high-stakes applications such as biopharmaceutical manufacturing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!